MiNK Therapeutics, Inc. (INKT) Misses Q4 EPS by 54c

MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q4 EPS of ($0.62), $0.54 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.

You May Also Be Interested In

• Putin, Xi, Trump may hold trilateral talks at APEC summit - Russia's Vesti
• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Medtronic jumps on earnings beat and raised guidance